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Abstract
Background: The objectives of this research were (a) to describe the current status of grant review for biomedical
projects and programmes from the perspectives of international funding organisations and grant reviewers, and (b)
to explore funders’ interest in developing uniform requirements for grant review aimed at making the processes
and practices of grant review more consistent, transparent, and user friendly.
Methods: A survey to a convenience sample of 57 international public and private organisations that give grants
for biomedical research was conducted. Nine participating organisations then emailed a random sample of their
external reviewers an invitation to participate in a second electronic survey.
Results: A total of 28 of 57 (49%) organisations in 19 countries responded. Organisations reported these problems
as frequent or very frequent: declined review requests (16), late reports (10), administrative burden (7), difficulty
finding new reviewers (4), and reviewers not following guidelines (4). The administrative burden of the process was
reported to have increased over the past 5 years. In all, 17 organisations supported the idea of uniform
requirements for conducting grant review and for formatting grant proposals. A total of 258/418 (62%) reviewers
responded from 22 countries. Of those, 48% (123/258) said their institutions encouraged grant review, yet only 7%
(17/258) were given protected time and 74% (192/258) received no academic recognition for this. Reviewers rated
these factors as extremely or very important in deciding to review proposals: 51% (131/258) desire to support
external fairness, 47% (120/258) professional duty, 46% (118/258) relevance of the proposal’s topic, 43% (110/258)
wanting to keep up to date, 40% (104/258) desire to avoid suppression of innovation. Only 16% (42/258) reported
that guidance from funders was very clear. In all, 85% (220/258) had not been trained in grant review and 64%
(166/258) wanted this.
Conclusions: Funders reported a growing workload of biomedical proposals that is getting harder to peer review.
Just under half of grant reviewers take part for the good of science and professional development, but many
report lack of academic and practical support and clear guidance. Around two-thirds of funders supported the
development of uniform requirements for the format and peer review of proposals to help ease the current
situation.
Background
Peer review for submissions to scientific journals has
developed over more than 300 years, and there is now a
considerable body of evidence on its methods, out-
comes, effectiveness, best practice, problems, and ethics
[1]. Peer review of applications for research grants has a
sparser evidence base and fewer examples of good prac-
tice for funders to draw on when developing their sys-
tems. This lack of evidence is worrying, because several
major funders of biomedical research have reported
recently that they are becoming overburdened by work-
loads and by the complexity and slowness of grant
review processes [2,3].
In contrast, editorial peer review at journals has a
much wider evidence base and is subject to continuous
review and debate. Strengths, weaknesses, ways to
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any medium, provided the original work is properly cited.reduce bias, and different models in journal peer review
have been studied extensively, yet many questions
remain unanswered. Although there is evidence on how
to conduct peer review fairly and efficiently, there is
only limited evidence that journal peer review improves
the quality of published biomedical science according to
aC o c h r a n er e v i e wt h a ts y s t e m a t i c a l l yr e v i e w e d2 8o f6 1
retrieved studies [4]. International congresses have been
held regularly since 1989 to present and share the latest
evidence and to develop further research questions, so
that biomedical journal editors can try to improve their
practices [5]. Additionally, several international organisa-
tions gather, further develop, and promote evidence to
guide editors; particularly the International Committee
of Medical Journal Editors (ICMJE) whose Uniform
Requirements for Manuscripts Submitted to Biomedical
Journals guidelines ensure the consistency and transpar-
ency of manuscripts and guide practice, processes and
policies at more than 800 journals [6]. There is, how-
ever, no equivalent resource for preparing grants and
conducting grant review.
There has been one Cochrane systematic review about
grant review practices, but it found evidence only on
biases and other process weaknesses and included only
10 studies [7]. The authors concluded ‘We were unable
to find comparative studies assessing the actual effect of
peer review procedures on the quality of the funded
research. There is little empirical evidence on the effects
of grant giving peer review. Experimental studies asses-
sing the effects of grant giving peer review on impor-
tance, relevance, usefulness, soundness of methods,
soundness of ethics, completeness and accuracy of
funded research are urgently needed. Practices aimed to
control and evaluate the potentially negative effects of
peer review should be implemented meanwhile’ [7].
Until the necessary studies of grant review are done,
might funders develop and use a set of uniform require-
ments, at least partly informed by the evidence on jour-
nal peer review?
Ernest Starling was an eminent physiologist who when
asked by the British Medical Research Council in the
1920s about how to best distribute funding answered ‘get
the best of men, give them the equipment you can afford,
and leave them alone’. Peer review is the main ‘equip-
ment’ used by research councils and other funders. To
explore the current status of grant review, the epon-
ymous ‘Starling Group’ of funders, policy makers,
researchers, and editors, who first met in Frankfurt to
discuss the European Medical Research Councils’ strategy
for medical research in Europe [3], initiated two surveys.
The first Starling Group study is an international sur-
vey to describe the current status of peer review among
biomedical funding organisations and the problems they
face when evaluating proposals for biomedical project
and programme grants. The second is a survey to deter-
mine the workload of external grant reviewers, the level
of institutional support for this activity, reviewers’ moti-
vations and perceived barriers to taking on grant review,
and their views on possible solutions. We report on
both surveys here.
Methods
Survey of biomedical funding organisations
Sample
We took a convenience sample of biomedical research
funding organisations across Europe and also
approached key national funders from North America,
Australia, and New Zealand to broaden the survey’s
reach and relevance; members of the Starling Group
suggested international public and private grant giving
organisations they thought should be included. We also
sought the advice of the European Foundation Centre
for suggestions for inclusions of private foundations in
E u r o p e .T h ef i n a ll i s to f5 7f u n d i n go r g a n i s a t i o n s
included both small and large international funding
organisations. The purpose was to include a range of
different funders from different countries to illustrate
some of the current problems they face rather than to
create a representative sample and draw inferences
beyond the sample.
Procedures
A draft questionnaire was developed based on discus-
sions with several funding organisations about current
practice and common problems with peer review. The
questionnaire was then refined by members of the Star-
ling Group and revised before field testing. The ques-
tionnaire asked participants to respond to all questions
in relation to grants that provide support for biomedical
studies addressing a single research question or research
theme (project and programme grants) not infrastruc-
ture grants or fellowships. We sent an invitation and
link to the electronic survey on SurveyMonkey (online
survey software; http://www.SurveyMonkey.com) to a
named contact person at the funding organisation
explaining the purpose of the research and requesting
their help. Non-responders were sent an email reminder
2 weeks and 6 weeks after the original mailing.
Survey of external grant reviewers
Sample
Funding organisations that took part in our first survey
were invited to survey a random sample of approxi-
mately 50 of their reviewers. Nine organisations agreed
to take part and emailed invitations to our survey to a
small sample of their external reviewers.
Procedures
A draft questionnaire was developed based on known
problems with grant peer review and previous research
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was then finalised by members of the Starling Group.
Reviewers were sent an email from their funder inform-
ing them of the survey with a link to the questionnaire
on SurveyMonkey. Reviewers were informed that the
survey was being conducted for research purposes by a
team interested in improving grant review processes and
that their responses would be confidential. All reviewers
were emailed a reminder by their funding organisation
to complete the survey approximately 2 weeks after the
initial mailing.
Results
Survey of biomedical funding organisations
Sample characteristics
We received a response from 29 (52%) of the 56 fun-
ders. Table 1 is a list of participating organisations.
Organisations were based in 19 countries, were funded
by various sources, and varied in size and the amount of
grant money administered. Six large organisations took
part. These receive over 1000 proposals a year, and
were: the US National Institutes of Health, the Canadian
Institutes of Health Research, The Wellcome Trust, the
National Health And Medical Research Council (of Aus-
tralia), the Deutsche Forschungsgemeinschaft (DFG),
and the Medical Research Council, UK. Of the 29
responding organisations, 2 do not use external
reviewers for project applications but use committees
instead (The Swedish Research Council and The Lund-
beck Foundation) and for this reason, they were
excluded from the analysis of specific questions regard-
ing external reviewers.
Peer review process
A total of 15/29 of the organisations reject 10% or less
of research project grant applications based on internal
review only. However, 13/29 of the organisations accept
30% or less of project grant applications following exter-
nal review. A total of 17/27 use an electronic tracking
system to contact external reviewers and manage their
reviews but few (6/29) use an electronic system for
grant applicants to track their proposals during each
stage of the decision-making process.
Selection of external reviewers
Only 13/27 organisations limit the number of annual
requests to external reviewers in order to reduce indivi-
dual burden and the potential for bias in the system.
However, 18/27 organisations invite more than 3 exter-
nal reviewers on average to review a single application.
In all, 16/27 use programme managers, 15/27 boards/
panels/committees, 6/27 board chairpersons, and 10/27
grant applicants to suggest external reviewers.
External reviewer guidelines and forms
The majority (22/27) provide guidelines for external
reviewers on what applications should be judged on, 22/
27 provide review forms or templates for external
reviewers to submit their reviews, and 21/27 a scoring/
ranking system to rate specific aspects of proposals.
Transparency of review process
Only 2/27 organisations hide the grant applicants’
names from the external reviewers whereas 21/27 hide
external reviewers’ names from applicants. Only 4/27
hide the names of all reviewers on the funding board/
panel from applicants. However, 5/27 organisations
commented that they make a list of reviewers’ names
available (for example, on their website) at the end of
the funding round.
During the review process, 7/27 organisations allow
grant applicants to see the full external reviewers’
reports, 3/27 the funding board/panels’ comments/
reports, and 5/27 the scores assigned to their applica-
tion. However, after the decision has been made on
their application, these figures rose to 16/27, 18/27, and
13/27, respectively. A total of 22/27 organisations routi-
nely ask their reviewers to declare their conflicts of
interest for each proposal reviewed.
Frequency of problems with specific aspects of peer review
Table 2 shows the frequency organisations reported they
experience problems with specific of aspects of peer
review. Problems reported as very frequent or frequent
by at least a quarter of the organisations included
reviewers declining to review (16/29) and receiving late
reports (10/29). None of the organisations reported very
frequent or frequent problems with having an inade-
quate number of reviewers’ reports available at time of
assessment, reviewers not declaring their conflicts of
interest, or reviewers breaking confidentiality.
Perceived change in specific aspects of peer review over the
last 5 years
Over half the sample perceived no change over the last 5
years in the following problems: having an inadequate
number of reviewers’ reports available at time of assess-
ment (15/29), receiving poor quality reviews (19/29),
receiving late reviews (19/29), reviewers not following
guidelines appropriately (20/29), reviewers not declaring
their conflicts of interest (16/29), reviewers breaking con-
fidentiality (16/29), applicants questioning the conflicts
of interest of reviewers (18/29), and applicants question-
ing the funder’s choice of reviewers (20/29) (Table 2).
Many organisations reported the situation was worse
now than 5 years ago for reviewers declining to review
(13/29), too many applications in the system (12/29),
and the administrative burden of process (11/29). Fun-
ders reported a better situation now than 5 years ago
for applicants recommending inappropriate reviewers
(18/29) reviewers declaring their conflicts of interest.
Most important challenges facing funding organisations
The self-reported most important challenges faced by
organisations included finding available and suitable
Schroter et al. BMC Medicine 2010, 8:62
http://www.biomedcentral.com/1741-7015/8/62
Page 3 of 9reviewers, problems with review quality and time taken
to complete reviews, and problems with administration
and transparency.
Reviewer incentives: feedback, acknowledgement, and
rewards
In all, 14/27 organisations routinely give external peer
reviewers the funding board/panel’s decision on the pro-
posal(s) they reviewed, but only 3/27 the details of their
discussions and decisions. Only about a quarter (7/27)
give feedback to reviewers on the usefulness of their
reviews.
Some organisations reward or acknowledge their
reviewers by naming them on their website (7/27), tell-
ing their institutions that they are reviewers for their
organisation (4/27), giving feedback on the quality of
their reviews (5/27), and by paying them (10/27). Other
ways of thanking them included: naming them in the
annual report, annual letters of thanks, informing those
Table 1 List of participating funding organisations
Organisation Country Funding basis
National Institutes of Health* (NIH) USA Government
Canadian Institutes of Health Research* Canada Government and small amount of support from donations;
additional funds through partnerships with private and public
sector agencies
Vetenskapsradet-Medicine (Swedish Research Council) Sweden Government
Fonds voor Wetenschappelijk Onderzoek (FWO) Belgium Private foundation and research council
The Health Foundation UK Independent foundation
Health Research Board of Ireland Ireland Government
The Netherlands Organisation of Health Research and Development
(ZonMw), also on behalf of the Netherlands Organisation of Scientific
Research (NWO)
The
Netherlands
Government
Swiss National Science Foundation Switzerland Private foundation
NETSCC, part of National Institute for Health Research (NIHR), in
England
UK Government
Estonian Science Foundation Estonia Government
The Research Council of Norway Norway Government (all the ministries)
Robert Bosch Stiftung Germany Private foundation
Foundation for Polish Science Poland Private foundation
Fondation Fournier Majoie pour l’Innovation Belgium Private foundation
National Institute for Health Research Central Commissioning Facility,
which runs four grant funding schemes on behalf of NIHR: Research
for Patient Benefit, Invention for Innovation and Research for
Innovation, Speculation and Creativity (all project grants) and
Programme Grants for Applied Research
UK Government
The Wellcome Trust* UK Charity
National Health And Medical Research Council (of Australia)* Australia Government
Fondazione Cariplo Milano Italy Private foundation
Telethon Foundation Italy Italy Charity
Juvenile Diabetes Research Foundation USA Charity
Health Research Council of New Zealand New
Zealand
Government
Medical Research Council, UK* UK Government
Deutsche Forschungsgemeinschaft* (DFG) Germany Government and private foundation
Hungarian Scientific Research Fund (OTKA) Hungary Government
Academy of Sciences of the Czech Republic. Grant Agency of the
Academy of Sciences of the Czech Republic
Czech
Republic
Government
Lundbeck Foundation, Copenhagen Denmark Charity, private foundation, commercial foundation
Fondation Mérieux France Private foundation
Fonds National de la Recherche Scientifique Belgium Private foundation
The Danish Medical Research Council Denmark Government
*Indicates large organisations (receiving over 1000 proposals a year).
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honorariums, giving formal confirmation if requested,
invitations to the grant delivery ceremony or inaugura-
tion dinners, emails of gratitude and feedback on
reviews if requested, allowing reviewers to submit grant
applications outside of call deadlines, reviewers’ award
programs, and dinner invitations.
Development of standards on grant review
We proposed that a set of standards, such as the ICMJE
guidelines [4] for the preparation and formatting of
manuscripts submitted for publication by biomedical
journals, drawn up for grant review might help enable
researchers, funders, and peer reviewers to practice
grant review more efficiently and effectively. We found
considerable support for the idea of the development of
a set of standards for the peer review process at grant
giving organisations: 17/29w o u l ds u p p o r tt h i si d e a ,
none would not, and 11/29 were unsure. There was also
good support for the development of a set of standards
for the grant application process: 17/29 would support
it, 2/29 would not, and 9/29 were unsure.
Survey of external grant reviewers
Sample characteristics
In all, 9 funding organisations took part and we received
an overall response of 258/418 (62%) (Table 3). Two-
thirds of respondents were male, and the majority (62%)
was aged 41 to 60 years. In all, 77% described them-
selves as researchers, 31% practicing clinicians, and 17%
laboratory scientists. Respondents were working in 22
countries and ranged in their experience of reviewing:
24% had been a grant reviewer for biomedical science
Table 2 Frequency organisations experience problems with specific aspects of peer review and perceived change
over time
Frequency of problem, n (%) Perceived change, n (%)
Never Occasionally Frequently Very
frequently
Not
applicable
Better
situation now
than 5 years
ago
No
change
Worse
situation now
than 5 years
ago
Not
applicable
Reviewers declining to review 0 (0) 9 (31) 14 (48) 2 (7) 1 (3) 2 (7) 9 (31) 13 (45) 3 (10)
Difficulty finding new
reviewers for your database
system
3 (10) 15 (52) 4 (14) 0 (0) 4 (14) 4 (14) 10 (35) 5 (17) 8 (28)
Difficulty retaining good
reviewers
4 (14) 17 (59) 1 (3) 0 (0) 3 (10) 3 (10) 14 (48) 4 (14) 5 (17)
Having an inadequate number
of reviewers’ reports available
at time of assessment
2 (7) 23 (79) 0 (0) 0 (0) 1 (3) 4 (14) 15 (52) 3 (10) 5 (17)
Receiving poor quality reviews 1 (3) 22 (76) 3 (10) 0 (0) 0 (0) 5 (17) 19 (66) 0 (0) 3 (10)
Receiving late reviewers’
reports
0 (0) 16 (55) 10 (35) 0 (0) 0 (0) 4 (14) 19 (66) 2 (7) 3 (10)
Reviewers not following
guidelines appropriately
2 (7) 20 (69) 4 (14) 0 (0) 0 (0) 5 (17) 20 (69) 0 (0) 3 (10)
Reviewers not declaring their
conflicts of interest
9 (31) 16 (55) 0 (0) 0 (0) 1 (3) 7 (24) 16 (55) 0 (0) 3 (10)
Reviewers breaking
confidentiality
9 (31) 12 (41) 0 (0) 0 (0) 5 (17) 1 (3) 16 (55) 0 (0) 8 (28)
Applicants questioning the
conflicts of interest of
reviewers
11
(38)
13 (45) 1 (3) 0 (0) 1 (3) 2 (7) 18 (62) 1 (3) 5 (17)
Applicants questioning the
funder’s choice of reviewers
4 (14) 18 (62) 1 (3) 1 (3) 2 (7) 2 (7) 20 (69) 0 (0) 5 (17)
Applicants recommending
inappropriate reviewers
3 (10) 11 (38) 4 (14) 0 (0) 7 (24) 18 (62) 0 (0) 0 (0) 9 (31)
Difficulty in recruiting younger
reviewers
9 (31) 8 (28) 2 (7) 1 (3) 6 (21) 6 (21) 11 (38) 2 (7) 6 (21)
Difficulty in recruiting female
reviewers
7 (24) 9 (31) 2 (7) 1 (3) 7 (24) 5 (17) 12 (41) 1 (3) 6 (21)
Too many grant applications
in the system
6 (21) 12 (41) 4 (14) 1 (3) 3 (10) 2 (7) 9 (31) 12 (41) 5 (17)
Administrative burden of
dealing with peer review
process
2 (7) 15 (52) 5 (17) 2 (7) 2 (7) 1 (3) 13 (45) 11 (38) 3 (10)
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Many respondents were reviewers for several funding
organisation; 44% (114/258) had reviewed for 3 or more
organisations in the past 12 months.
Time to review
Reviewers were asked to indicate approximately how long
it takes them to review a single biomedical science grant
proposal (including time reading proposal, making notes,
writing comments, completing assessment sheets, attend-
ing committees and panels). Only 15% (39/258) said that
the whole process took them less than or equal to 3 hours;
30% (77/258) spend on average between 4 and 6 hours, 9%
(22/258) spend 7 to 9 hours, 17% (44/258) spend 10 to 24
hours and 10% (27/258) spend more than 24 hour.
Institutional support
A total of 48% (123/258) said their institution or man-
agers encouraged them to take part in biomedical
science grant review, yet only 14% (37/258) said their
institution or managers knew how much time they
spent reviewing and 31% (79/258) knew which funding
organisations they reviewed for. A total of 32% (82/258)
were expected to review grants in their own time (that
is, out of office hours) and only 7% (17/258) were given
protected time to conduct grant review. In all, 28% (73/
258) said they always conduct biomedical science grant
review in their own time, 44% (113/258) often do, 19%
(49/258) occasionally and only 1% (2/258) never do.
Academic recognition
A total of 74% (192/258) do not receive any academic
recognition for conducting grant review. Comments
from the 43 who said they did included the fact that it
contributes to promotional review, is recognised within
the ‘indicators of esteem’ element of the UK’s Research
Assessment Exercise, is one of the metrics for assessing
research portfolios in clinical departmental review, is a
recognised research service when applying for grants
and fellowships, and prestige.
Importance of specific factors in decision to do
grant review
Reviewers rated the following as extremely or very
important in their decision to review: 51% (131/258) to
help external fairness in decision taking by review
committees, 47% (120/258) sense of professional duty,
46% (118/258) relevance of the topic, 43% (110/258)
wanting to keep up to date on research advances, 40%
(104/258) to help ensure innovation is not suppressed
(Table 4). In all, 30% (77/258) said the most important
motivating factor was a sense of professional duty, 14%
(35/258) the opportunity to learn something new, 14%
(35/258) to keep up to date on research advances, and
12% (31/258) wanting to help external fairness in deci-
sion taking.
Training and guidance in grant review
Only 9% (22/258) had received some formal training in
how to conduct biomedical science grant review and
64% (166/258) said they would be interested in receiving
training if funding organisations provided it (free of
charge). Whilst 63% (162/258) reported that instructions
and guidance for external reviewers provided by biome-
dical science funding organisations are quite clear and
that they usually know what they are expect to do as a
reviewer, only 16% (42/258) said that these were very
clear and they always know what they are expected to
do. Only 9% (23/258) reported that the clarity of
instructions and guidance varied by organisation.
Barriers to reviewing
At least 25% of the reviewers reported the following
factors often or always acted as barriers to undertaking
grant review: conflicts with other workload (47%, 121/
258), having to review too many journal articles (36%,
93/258), reviewing taking too much time (33%, 85/
258), insufficient knowledge on the focus of the appli-
cation (31%, 80/258), tight deadlines for completing
the review (28%, 71/258), and having to review too
Table 3 Participating funding organisations and the response rates
Organisation Country Number of surveys sent
out*
Number of surveys
completed
Response rate
(%)
Fonds voor Wetenschappelijk Onderzoek (FWO) Belgium 41 19 46
Deutsche Forschungsgemeinschaft (DFG) Germany 49 32 65
National Health And Medical Research Council (of Australia) Australia 50 42 84
Hungarian Scientific Research Fund (OTKA) Hungary 50 36 72
NIHR Coordinating Centre for Health Technology Assessment
(NCCHTA)
UK 50 22 44
Estonian Science Foundation Estonia 50 38 76
Telethon Italy Italy 49 24 49
The Research Council of Norway Norway 31 19 61
National Institute for Health Research Central Commissioning
Facility
UK 48 26 54
Total 418 258 62
*After correcting for email delivery failures.
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64/258) (Table 5).
Suggestions on how funding organisations might better
identify and retain grant reviewers
We solicited suggestions on how the problem of some
funding organisations finding it difficult to both identify
new and retain current grant reviewers might be
improved. We received numerous constructive suggestions
and grouped these by broad themes. Recurring themes
included the need for: public acknowledgement, some
kind of reward or reimbursement, institutions to recognise
the importance of reviewing as an activity, tips for making
reviewing easier, more internal reviewing/screening of
applications, improved guidance and training, improved
feedback and communication, improved administration,
greater transparency, funding of more applications, an
Table 4 Importance of specific factors in reviewers’ decisions to conduct review
Not at all
important, n
(%)
Slightly
important, n
(%)
Important,
n (%)
Very
important, n
(%)
Extremely
important, n
(%)
Most important
factor, n (%)
Opportunity to learn something new 5 (2) 46 (18) 98 (38) 70 (27) 24 (9) 35 (14)
Wanting to keep up to date on research
advances in specific areas
7 (3) 39 (15) 88 (34) 85 (33) 25 (10) 35 (14)
Relevance of the topic to your own work or
interests
5 (2) 35 (14) 85 (33) 91 (35) 27 (11) 25 (10)
Wanting to enhance your CV and career
prospects
85 (33) 98 (38) 37 (14) 20 (8) 3 (1) 6 (2)
Reputation of the funding organisation 25 (10) 65 (25) 104 (43) 41 (16) 7 (3) 2 (1)
Wanting to get known as a reviewer 94 (36) 65 (25) 60 (23) 16 (6) 4 (2) 4 (2)
A sense of professional duty 9 (4) 19 (7) 93 (36) 82 (32) 38 (15) 77 (30)
Wanting to help pay back the efforts of
others
18 (7) 49 (19) 92 (36) 67 (26) 16 (6) 10 (4)
Wanting to help external fairness in decision
taking by grant review committees
8 (3) 22 (9) 82 (32) 88 (34) 43 (17) 31 (12)
Wanting to help ensure innovation is not
suppressed
9 (4) 40 (16) 87 (34) 70 (27) 34 (13) 7 (3)
Wanting to keep your reviewing skills up to
date
49 (19) 62 (24) 77 (30) 41 (16) 11 (4) 1 (1)
Percentages do not sum to 100% due to rounding and/or missing data.
Table 5 Frequency of specific factors cited by reviewers as barriers to undertaking grant review
Never, n
(%)
Sometimes, n
(%)
Often, n
(%)
Always, n
(%)
Not applicable, n
(%)
Insufficient interest in the focus of the application 32 (12) 152 (59) 39 (15) 8 (3) 7 (3)
Insufficient knowledge on the focus of the application 14 (5) 136 (53) 50 (19) 30 (12) 9 (4)
Having to review too many grants for funding organisations 46 (18) 114 (44) 54 (21) 10 (4) 12 (5)
Having to review too many journal articles 38 (15) 99 (38) 74 (29) 19 (7) 8 (3)
Long grant applications 67 (26) 104 (40) 47 (18) 10 (4) 9 (4)
Poor quality of the grant applications 67 (26) 107 (42) 38 (15) 12 (5) 11 (4)
Reviewing taking too much time 35 (14) 111 (43) 68 (26) 17 (7) 5 (2)
Inadequate guidance on the requirements for review 116 (45) 98 (38) 15 (6) 2 (1) 7 (3)
Believing that there is a more appropriate reviewer for the
application
32 (12) 162 (63) 33 (13) 6 (2) 5 (2)
Tight deadlines for completing the review 36 (14) 125 (48) 59 (23) 12 (5) 4 (2)
Conflicts with other workload 25 (10) 85 (33) 81 (31) 40 (16) 6 (2)
Lack of formal recognition of reviewer contributions 134 (52) 56 (22) 25 (10) 12 (5) 6 (2)
Not being paid for reviewing 141 (55) 52 (20) 19 (7) 13 (5) 9 (4)
Not being paid enough for reviewing 160 (62) 28 (11) 16 (6) 7 (3) 24 (9)
Having conflicting interests with the applicants 68 (26) 126 (49) 17 (7) 20 (8) 7 (3)
Your own success rate with the funder 163 (63) 50 (19) 7 (3) 1 (1) 14 (5)
Lack of fluency in the language in which the proposal is written 172 (67) 35 (14) 3 (1) 4 (2) 23 (9)
Percentages do not sum to 100% due to rounding and/or missing data.
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and some suggestions for alternative review systems.
Discussion
Our survey of funding organisations showed that fun-
ders are challenged by an increasing number of applica-
tions and frequent difficulty in finding willing and
available reviewers. Some organisations emphasised the
need for streamlining and more efficient administrative
systems and we found support for the idea of uniform
requirements for proposals. The survey of external
reviewers showed that reviewers are motivated by a
sense of professional duty and fairness despite not
receiving academic recognition and frequently having to
undertake this time-consuming work in their own time.
Reviewers also indicated that they are often sent
requests for reviews outside of their expertise suggesting
that funding organisations are having difficulty targeting
the appropriate reviewers. We also identified a need for
improved guidance and training on how to review.
These findings are similar to the problems journals
experience with peer review [1].
This international survey included a diverse range of
funding organisations and identified common problems.
We are unaware of any other studies attempting to col-
lect data from funding organisations with such breadth
and geographical reach, although individual organisa-
tions, particularly the US National Institutes of Health
(NIH) [8], have conducted their own internal reviews.
We acknowledge that 29 organisations is still a small
number of grant giving organisations, that we used con-
venience sampling which could have introduced bias,
and that the response rate to this survey was low (52%).
Similarly, our reviewers’ survey is the first large survey
of external grant reviewers from a range of funding
organisations. We asked reviewers about their reviewing
practices in general rather than isolated experiences
with specific funders, to make the results more generali-
sable to the wider population of reviewers and funders.
We achieved a good response rate (62%) from the
reviewers similar to the response rate we have achieved
with surveys of journal peer reviewers [9].
The ICMJE set an editorial precedent for the develop-
ment of uniform requirements. A similar set of guide-
lines on grant review might enable researchers, funders,
and peer reviewers to practise grant review more consis-
tently and, we hope, more efficiently and effectively.
Most of the funding organisations in the survey were
receptive to the idea of such standards for grant review
and reviewers indicated problems with heterogeneous
requirements from funders. Further exploration of the
feasibility and acceptability of uniform requirements for
grant review is required.
With a bursting system reliant on good will, is it
time for all funding organisations to more formally
recognise contributions from reviewers through, for
example, public acknowledgement, certificates, or
rewards? Funding organisations should help reviewers
to do their job effectively by providing clear guidance
and training as well as improved feedback and commu-
nication. We are not the first to advocate the need for
nurturing reviewers [10], but most have focused on
journal peer review and grant review seems relatively
neglected.
Conclusions
The workload of biomedical research funders is growing.
Our surveys suggest that few funders have used their
experiences of deteriorating efficiency or the (albeit lim-
i t e d )e v i d e n c eb a s eo ne d i t o rial peer review to assess
and improve their processes. We suggest that funders
provide clearer guidance to reviewers, draw on evidence
from both editorial and grant review to maximise the
efficiency and fairness of their work, and come together
to consider the development of a set of uniform require-
ments for submitting and peer reviewing biomedical
grant proposals.
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